{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:51:47Z","timestamp":1753876307415,"version":"3.41.2"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Immunotherapy has become a pillar of modern oncological management but is associated with significant immunotherapy-related adverse events (IRAEs). While myocarditis is a prominent IRAE which clinicians are increasingly aware of, immunotherapy-related coronary vasospasm is far less appreciated and can be especially difficult to elucidate in pre-existing coronary artery disease. This case demonstrates the approach to diagnosis and management of multiple cardiovascular and non-cardiovascular IRAEs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 57-year-old male with a history of metastatic melanoma on combined immunotherapy and ischaemic heart disease with multiple previous percutaneous coronary interventions presented with typical chest pain and troponin rise. Differential diagnoses for this presentation included a non-ST elevation myocardial infarction, myocarditis, and coronary vasospasm. Coronary angiogram did not reveal any new significant obstructive coronary artery disease while cardiac MRI did not reveal any radiological features consistent with myocarditis. However, empirical treatment for IRAEs resulted in both clinical and biochemical improvement and ability to discharge the patient on steroids and coronary vasodilators, having been GTN-infusion dependent as an inpatient.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Cardiovascular IRAEs are important to be aware of when managing patients on immunotherapy and more than one IRAE can occur concurrently. Given the caveats of non-invasive imaging and invasive nature of endomyocardial biopsy, the clinical history is key in establishing these crucial diagnoses which will significantly impact ongoing oncological management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytae620","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T12:51:58Z","timestamp":1732020718000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunotherapy-mediated myocarditis and concurrent vasospastic angina in a patient with established ischaemic heart disease: a case report"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2714-5392","authenticated-orcid":false,"given":"Jefferson","family":"Ko","sequence":"first","affiliation":[{"name":"Department of Cardio-oncology, Victorian Heart Hospital , 631 Blackburn Road, Clayton, Melbourne, VIC 3168 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wardill","sequence":"additional","affiliation":[{"name":"Department of Cardio-oncology, Victorian Heart Hospital , 631 Blackburn Road, Clayton, Melbourne, VIC 3168 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2772-0695","authenticated-orcid":false,"given":"Sean","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Cardio-oncology, Victorian Heart Hospital , 631 Blackburn Road, Clayton, Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Cardio-oncology, Victorian Heart Institute , 631 Blackburn Road, Clayton, Melbourne, VIC 3168 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3941-8693","authenticated-orcid":false,"given":"Satish","family":"Ramkumar","sequence":"additional","affiliation":[{"name":"Department of Cardio-oncology, Victorian Heart Hospital , 631 Blackburn Road, Clayton, Melbourne, VIC 3168 ,","place":["Australia"]},{"name":"Department of Cardio-oncology, Victorian Heart Institute , 631 Blackburn Road, Clayton, Melbourne, VIC 3168 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"2024122016511057900_ytae620-B1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41467-022-27960-2","article-title":"Immune-related adverse events and the Balancing Act of Immunotherapy","volume":"13","author":"Conroy","year":"2022","journal-title":"Nat Commun"},{"key":"2024122016511057900_ytae620-B2","doi-asserted-by":"crossref","first-page":"726426","DOI":"10.3389\/fcvm.2021.726426","article-title":"Immune checkpoint inhibitors and the heart","volume":"8","author":"Mocan-Hognogi","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2024122016511057900_ytae620-B3","doi-asserted-by":"crossref","first-page":"1167975","DOI":"10.3389\/fimmu.2023.1167975","article-title":"Immune-related adverse events of immune checkpoint inhibitors: a review","volume":"14","author":"Yin","year":"2023","journal-title":"Front Immunol"},{"key":"2024122016511057900_ytae620-B4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4330\/wjc.v12.i11.584","article-title":"Cardiac adverse events of immune checkpoint inhibitors in oncology patients: a systematic review and meta-analysis","volume":"12","author":"Nso","year":"2020","journal-title":"World J Cardiol"},{"key":"2024122016511057900_ytae620-B5","doi-asserted-by":"crossref","first-page":"e013757","DOI":"10.1161\/JAHA.119.013757","article-title":"Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment","volume":"9","author":"Palaskas","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2024122016511057900_ytae620-B6","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2024122016511057900_ytae620-B7","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024122016511057900_ytae620-B8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10554-020-02097-9","article-title":"Use of the new Lake Louise criteria improves CMR detection of atypical forms of acute myocarditis.","volume":"37","author":"Cundari","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"2024122016511057900_ytae620-B9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/eurheartj\/ehaa051","article-title":"Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis","volume":"41","author":"Zhang","year":"2020","journal-title":"Eur Heart J"},{"key":"2024122016511057900_ytae620-B10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00330-010-2022-1","article-title":"Magnetic resonance imaging findings in acute myocarditis and correlation with immunohistological parameters.","volume":"21","author":"R\u00f6ttgen","year":"2011","journal-title":"Eur Radiol"},{"key":"2024122016511057900_ytae620-B11","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2169\/internalmedicine.8540-21","article-title":"Vasospastic angina: an immune-related adverse event","volume":"61","author":"Kumamoto","year":"2022","journal-title":"Internal Medicine"},{"key":"2024122016511057900_ytae620-B12","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.117.030571","article-title":"Clinical features, management, and outcomes of immune checkpoint inhibitor-related cardiotoxicity","volume":"136","author":"Escudier","year":"2017","journal-title":"Circulation"},{"key":"2024122016511057900_ytae620-B13","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehz796","article-title":"Vasospastic angina following immune checkpoint blockade","volume":"41","author":"Otsu","year":"2020","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytae620\/60748015\/ytae620.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/12\/ytae620\/60951602\/ytae620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/12\/ytae620\/60951602\/ytae620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T16:51:34Z","timestamp":1734713494000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytae620\/7903118"}},"subtitle":[],"editor":[{"given":"Diego","family":"Araiza-Garaygordobil","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Albert","family":"Galyavich","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Cuiro","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Diego","family":"Araiza-Garaygordobil","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Maria Isabel Gonzalez","family":"del Hoyo","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytae620","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,11,19]]},"article-number":"ytae620"}}